31-Aug-2024 8:11 AM CST - Insider Monkey Builders FirstSource Inc. (BLDR): Jim Cramer's Go-To Stock For Success We recently compiled a list of the Jim Cramer's 10 Go-To Stocks for Success. In this article, we are going to take a look at where Builders FirstSource Inc. (NASDAQ:BLDR) stands against Jim Cramer's other go-to stocks for success.
28-Aug-2024 5:57 PM CST - CNBC Cramer's Lightning Round: Builders FirstSource 'can go higher' Builders FirstSource: "...This thing can go higher. This is precisely the kind of stock you should be buying at this stage in the cycle. Hold on." Vertex Pharmaceuticals: "I think Vertex is great." Viking Therapeutics: "...Here's the problem: it costs so ...
7-Aug-2024 11:21 AM CST - Seeking Alpha Builders FirstSource upgraded at Baird on revised outlook Builders FirstSource (NYSE:BLDR) on Wednesday was upgraded to Outperform from a previous investment rating of Neutral by analysts at financial-services firm Baird. They said the distributor of construction materials is poised to gain on revised expectations.
31-Aug-2024 8:11 AM CST - Insider Monkey Builders FirstSource Inc. (BLDR): Jim Cramer's Go-To Stock For Success We recently compiled a list of the Jim Cramer's 10 Go-To Stocks for Success. In this article, we are going to take a look at where Builders FirstSource Inc. (NASDAQ:BLDR) stands against Jim Cramer's other go-to stocks for success.
28-Aug-2024 5:57 PM CST - CNBC Cramer's Lightning Round: Builders FirstSource 'can go higher' Builders FirstSource: "...This thing can go higher. This is precisely the kind of stock you should be buying at this stage in the cycle. Hold on." Vertex Pharmaceuticals: "I think Vertex is great." Viking Therapeutics: "...Here's the problem: it costs so ...
7-Aug-2024 11:21 AM CST - Seeking Alpha Builders FirstSource upgraded at Baird on revised outlook Builders FirstSource (NYSE:BLDR) on Wednesday was upgraded to Outperform from a previous investment rating of Neutral by analysts at financial-services firm Baird. They said the distributor of construction materials is poised to gain on revised expectations.
